Total Payments
$7,869
2024 Payments
$2,510
Companies
31
Transactions
376
Medicare Patients
13,124
Medicare Billing
$679,238
Payment Breakdown by Category
Food & Beverage$7,780 (98.9%)
Education$88.99 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,780 | 374 | 98.9% |
| Education | $88.99 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,205 | 55 | $0 (2024) |
| Amgen Inc. | $1,051 | 69 | $0 (2024) |
| Novo Nordisk Inc | $1,036 | 46 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $667.06 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $629.33 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $587.07 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $469.22 | 21 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $337.03 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $288.22 | 12 | $0 (2024) |
| Lilly USA, LLC | $276.83 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,510 | 115 | ABBVIE INC. ($368.91) |
| 2023 | $1,801 | 79 | AbbVie Inc. ($377.71) |
| 2022 | $978.31 | 47 | ABBVIE INC. ($347.53) |
| 2021 | $744.55 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($224.98) |
| 2020 | $280.02 | 9 | GlaxoSmithKline, LLC. ($115.56) |
| 2019 | $217.68 | 13 | Novo Nordisk Inc ($70.48) |
| 2018 | $691.17 | 36 | Amgen Inc. ($220.41) |
| 2017 | $646.25 | 48 | Amgen Inc. ($162.36) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.33 | General |
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Biological | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Obesity | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.58 | General |
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Analgesic | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Insomnia | ||||||
| 11/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Analgesic | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Oncology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Biological | ||||||
| 10/28/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Analgesic | ||||||
| 10/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.31 | General |
| 10/24/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes Care | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,654 | 3,731 | $596,205 | $137,075 |
| 2022 | 37 | 3,347 | 5,268 | $588,400 | $161,139 |
| 2021 | 36 | 3,386 | 5,685 | $617,015 | $180,296 |
| 2020 | 39 | 3,737 | 6,304 | $744,943 | $200,727 |
Total Patients
13,124
Total Services
20,988
Medicare Billing
$679,238
Procedure Codes
141
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 478 | $196,555 | $50,616 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 144 | 144 | $88,560 | $21,304 | 24.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 37 | 37 | $40,990 | $10,443 | 25.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 97 | 99 | $39,105 | $8,637 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 88 | $25,785 | $6,005 | 23.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 210 | 349 | $22,185 | $4,580 | 20.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 219 | 399 | $17,655 | $4,131 | 23.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 52 | 52 | $14,840 | $3,866 | 26.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 173 | 219 | $17,095 | $3,591 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 223 | 411 | $13,350 | $3,444 | 25.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 214 | 363 | $12,425 | $2,770 | 22.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 85 | 87 | $9,900 | $2,511 | 25.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 175 | 201 | $30,915 | $2,485 | 8.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 62 | $5,935 | $2,195 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,680 | $1,956 | 25.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 84 | 84 | $7,560 | $1,790 | 23.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 122 | 144 | $6,960 | $1,364 | 19.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 37 | 37 | $3,515 | $1,331 | 37.9% |
| 92587 | Placement of ear probe for computerized measurement of sound with interpretation and report | Office | 2023 | 67 | 67 | $21,440 | $1,083 | 5.1% |
| 86803 | Hepatitis c antibody measurement | Office | 2023 | 45 | 46 | $2,460 | $658.91 | 26.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 34 | 35 | $2,450 | $512.04 | 20.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 105 | 115 | $1,725 | $362.15 | 21.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 21 | 26 | $1,690 | $341.61 | 20.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 17 | 18 | $1,530 | $324.36 | 21.2% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 28 | 38 | $1,900 | $294.87 | 15.5% |
About Dr. Lisa Walters, DO
Dr. Lisa Walters, DO is a Internal Medicine healthcare provider based in Oceanside, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548227937.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Walters, DO has received a total of $7,869 in payments from pharmaceutical and medical device companies, with $2,510 received in 2024. These payments were reported across 376 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,780).
As a Medicare-enrolled provider, Walters has provided services to 13,124 Medicare beneficiaries, totaling 20,988 services with total Medicare billing of $679,238. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Oceanside, NY
- Active Since 04/28/2006
- Last Updated 12/20/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1548227937
Products in Payments
- JARDIANCE (Drug) $521.69
- Wegovy (Drug) $456.99
- VRAYLAR (Drug) $416.40
- UBRELVY (Drug) $380.07
- QUVIVIQ (Drug) $337.03
- QULIPTA (Drug) $331.54
- FARXIGA (Drug) $325.41
- Otezla (Drug) $283.22
- TRELEGY ELLIPTA (Drug) $270.57
- Prolia (Biological) $270.26
- Aimovig (Biological) $234.67
- Ozempic (Drug) $226.97
- Veozah (Drug) $178.48
- EVENITY (Biological) $175.81
- Kerendia (Drug) $166.47
- BELSOMRA (Drug) $156.37
- TRULICITY (Drug) $155.41
- ZTLido (Drug) $150.22
- AIRSUPRA (Drug) $139.18
- JANUMET (Drug) $118.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oceanside
Karim El-Sherief, Md, MD
Internal Medicine — Payments: $39,242
Internal Medicine $39,242
Mrs. Pilar Stevens-Haynes, Md, MD
Internal Medicine — Payments: $19,555
Internal Medicine $19,555
Aaron Yung, M.d, M.D
Internal Medicine — Payments: $18,236
Internal Medicine $18,236
Dr. Ashish Kabra, Md, MD
Internal Medicine — Payments: $11,352
Internal Medicine $11,352
Dr. Karanbir Brar, M.d, M.D
Internal Medicine — Payments: $9,637
Internal Medicine $9,637
Dr. Pranay Srivastava, M.d, M.D
Internal Medicine — Payments: $8,863
Internal Medicine $8,863